Roman Butler Fullerton & CO Eli Lilly & CO Transaction History

Roman Butler Fullerton & CO

$334 Million
Q3 2024

A detailed history of Roman Butler Fullerton & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 10,027 shares of LLY stock, worth $7.97 Million. This represents 2.66% of its overall portfolio holdings.

Number of Shares

10,027

Previous 9,905 1.23%

Holding current value

$7.97 Million

Previous $8.97 Million 0.94%

% of portfolio

2.66%

Previous 3.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$772.14 - $960.02 $94,201 - $117,122	122 Added 1.23%	10,027 $8.88 Million
Q2 2024 Jul 15, 2024	BUY	$724.87 - $909.04 $46,391 - $58,178	64 Added 0.65%	9,905 $8.97 Million
Q1 2024 Apr 29, 2024	BUY	$592.2 - $792.28 $31,386 - $41,990	53 Added 0.54%	9,841 $7.66 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $93,483 - $110,205	-178 Reduced 1.79%	9,788 $5.71 Million
Q3 2023 Oct 18, 2023	BUY	$434.7 - $599.3 $36,514 - $50,341	84 Added 0.85%	9,966 $5.35 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $194,309 - $259,814	554 Added 5.94%	9,882 $4.63 Million
Q1 2023 Apr 27, 2023	SELL	$310.63 - $364.82 $456,315 - $535,920	-1,469 Reduced 13.61%	9,328 $3.2 Million
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $3,537 - $4,121	-11 Reduced 0.1%	10,797 $0
Q3 2022 Oct 17, 2022	SELL	$296.48 - $337.87 $549,377 - $626,073	-1,853 Reduced 14.64%	10,808 $3.54 Million
Q2 2022 Jul 26, 2022	BUY	$278.73 - $327.27 $1.35 Million - $1.58 Million	4,833 Added 61.74%	12,661 $4.2 Million
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $1.06 Million - $1.31 Million	4,507 Added 135.71%	7,828 $2.24 Million
Q4 2021 Jan 24, 2022	BUY	$224.85 - $279.04 $224 - $279	1 Added 0.03%	3,321 $917,000
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $5,096 - $6,272	-23 Reduced 0.69%	3,320 $793,000
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $361 - $467	2 Added 0.06%	3,343 $767,000
Q1 2021 Apr 22, 2021	BUY	$164.32 - $212.72 $72,793 - $94,234	443 Added 15.29%	3,341 $621,000
Q4 2020 Feb 01, 2021	BUY	$130.46 - $172.63 $29,483 - $39,014	226 Added 8.46%	2,898 $489,000
Q3 2020 Oct 15, 2020	BUY	$146.22 - $169.13 $292 - $338	2 Added 0.07%	2,672 $395,000
Q2 2020 Jul 28, 2020	BUY	$136.42 - $164.18 $136 - $164	1 Added 0.04%	2,670 $438,000
Q1 2020 Apr 13, 2020	BUY	$119.05 - $147.35 $238 - $294	2 Added 0.07%	2,669 $370,000
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $106 - $132	1 Added 0.04%	2,667 $351,000
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $35,133 - $38,216	-329 Reduced 10.98%	2,666 $298,000
Q2 2019 Jul 22, 2019	BUY	$110.79 - $129.32 $443 - $517	4 Added 0.13%	2,995 $332,000
Q1 2019 Apr 24, 2019	BUY	$111.31 - $131.02 $114,649 - $134,950	1,030 Added 52.52%	2,991 $388,000
Q4 2018 Feb 04, 2019	BUY	$105.9 - $118.64 $207,669 - $232,653	1,961 New	1,961 $227,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.

Account

Roman Butler Fullerton & CO Eli Lilly & CO Transaction History